FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first treatment for pediatric patients with lupus
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA permits marketing of first medical device for treatment of ADHD
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first generic naloxone nasal spray to treat opioid overdose
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first targeted therapy for metastatic bladder cancer
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA expands approved use of metastatic breast cancer treatment to include male patients
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- FDA approves treatment for patients with a type of inflammatory arthritis
- FDA approves a new generic valsartan
- FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor's office or clinic
- FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain
- FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer's disease
- FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder
- FDA approves first generic Advair Diskus